BioNeutra Global Corp. engages in the in the business of research and development, production, and commercialization of ingredients for nutraceutical, functional, and mainstream foods and beverages. The company is headquartered in Edmonton, Alberta. The company went IPO on 2014-11-05. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The company produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn, into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.
BioNeutra Global Corporation'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Inter Action Corporation'in toplam varlıkları $0 olup, net 損失 $0'dir.
BGACF'ün temel finansal oranları nelerdir?
Inter Action Corporation'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
BioNeutra Global Corporation'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Inter Action Corporation の最大収益セグメントは Internet of Things で、最新の利益発表における収益は 3,829,961,000 です。地域別に見ると、Japan が Inter Action Corporation の主要市場であり、収益は 4,542,794,000 です。
BioNeutra Global Corporation kârlı mı?
いいえ, son mali tablolara göre Inter Action Corporation'in net 損失 $0'dir.
BioNeutra Global Corporation'in herhangi bir yükümlülüğü var mı?
いいえ, Inter Action Corporation'in yükümlülüğü 0'dir.
BioNeutra Global Corporation'in tedavüldeki hisse sayısı kaçtır?
Inter Action Corporation'in toplam tedavüldeki hisse sayısı 0'dir.